Neotropix, Inc.
351 Phoenixville Pike
Malvern
Pennsylvania
19355
United States
Tel: 610-296-8660
Fax: 610-296-8661
Website: http://www.neotropix.com/
Email: info@neotropix.com
5 articles about Neotropix, Inc.
-
Neotropix, Inc. Announces Enrollment of Patients in National Cancer Institute-Sponsored Phase II Clinical Trial for Small Cell Lung Cancer
5/14/2010
-
Neotropix, Inc. Announces Presentation of Relevant Preclinical Results of NTX-010 in Pediatric Oncology Models
10/22/2008
-
Neotropix, Inc. Announces Expansion of On-Going Clinical Trial for Adult Neuroendocrine Cancers
10/8/2008
-
Neotropix, Inc. Appoints Anthony Williams, M.D., As Its Chief Medical Officer
9/23/2008
-
Neotropix, Inc. Receives FDA Approval To Begin Clinical Trials With First Investigational Cancer Drug
5/17/2006